| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 5,104,182 | 6,924,437 | ||
| Restricted cash | 50,000 | 50,000 | ||
| Accounts receivable | 976,984 | 739,473 | ||
| Amount due from related parties | 9,528,747 | 2,889,246 | ||
| Inventories | 18,431 | 54,280 | ||
| Deposits, prepayments and other receivables | 11,155,320 | 8,344,017 | ||
| Total current assets | 26,833,664 | 19,001,453 | ||
| Property plant and equipment gross | 367,672 | 379,468 | ||
| Less accumulated depreciation | 304,591 | 304,961 | ||
| Plant and equipment, net | 63,081 | 74,507 | ||
| Intangible assets, gross | 550,208 | 568,548 | ||
| Less accumulated depreciation | 530,542 | 542,165 | ||
| Intangible assets | 19,666 | 26,383 | ||
| Right of use assets, net operating leases | 87,814 | 96,512 | ||
| Deferred tax asset | 9,763 | 57,688 | ||
| Total non-current assets | 180,324 | 255,090 | ||
| Total assets | 27,013,988 | 19,256,543 | ||
| Amount due to shareholder | - | 0 | ||
| Accounts payable | 1,928,951 | 7,747,550 | ||
| Accrued liabilities and other payables | 11,094,739 | 11,667,409 | ||
| Contract liabilities | 692,652 | 893,663 | ||
| Amounts due to related parties | 2,350,223 | 2,444,113 | ||
| Loan | 116,040 | - | ||
| Lease liabilities operating leases | 54,429 | 75,692 | ||
| Total current liabilities | 16,237,034 | 22,828,427 | ||
| Lease liabilities operating leases | 34,690 | 22,109 | ||
| Other payables | 115,725 | 110,239 | ||
| Total non-current liabilities | 150,415 | 132,348 | ||
| Total liabilities | 16,387,449 | 22,960,775 | ||
| Treasury stock | 8 | 8 | ||
| Series x super voting preferred stock, 0.0001 par value, 75,000 shares designated 75,000 and 0 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively-Series XPreferred Stock | - | 8 | ||
| Series x super voting preferred stock, 0.0001 par value, 75,000 shares designated 75,000 and 0 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively-Series XPreferred Stock | 8 | - | ||
| Common stock, par value us0.0001, 200,000,000 shares authorized, 19,379,168 and 14,000,000 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 1,938 | 1,507 | ||
| Additional paid-in capital | 18,896,252 | 3,692,364 | ||
| Accumulated other comprehensive income | 479,991 | 318,428 | ||
| Accumulated deficit | -6,872,097 | -5,908,407 | ||
| Total equity attributable to nusatrip incorporated | 12,506,084 | -1,896,108 | ||
| Non-controlling interest | -1,879,545 | -1,808,124 | ||
| Total equity (deficit) | 10,626,539 | -3,704,232 | ||
| Total liabilities and equity | 27,013,988 | 19,256,543 | ||
NUSATRIP Inc (NUTR)
NUSATRIP Inc (NUTR)